Resmed (RMD) Total Non-Current Liabilities (2010 - 2026)

Resmed has reported Total Non-Current Liabilities for 17 years, with the latest figure at $941.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 12.87% year-over-year to $941.2 million; the trailing twelve-month figure through Mar 2026 stood at $941.2 million (down 12.87% YoY), and the FY2025 full-year result was $1.2 billion, up 8.17% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $941.2 million, up from $934.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $2.2 billion in Q4 2022, with the low at $931.6 million in Q3 2025.
• Historically, Total Non-Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 127.85% — and 2024, when it tumbled 41.09%.
• Resmed's Total Non-Current Liabilities stood at $2.2 billion in 2022, then dropped by 24.76% to $1.7 billion in 2023, then sank by 37.54% to $1.0 billion in 2024, then dropped by 9.84% to $934.4 million in 2025, then advanced by 0.73% to $941.2 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $941.2 million (Q1 2026), $934.4 million (Q4 2025), and $931.6 million (Q3 2025), per Business Quant data.